Showing results 15 to 34 of 168
< previous
next >
| Issue Date | Title | Author(s) |
| Mar-2012 | Bioactive sphingolipids in docetaxel-induced apoptosis in human prostate cancer cells | Başsoy, Esen Yonca; Baran, Yusuf |
| May-2011 | Bioactive sphingolipids in response to chemotherapy: A scope on Leukemias | Ekiz, Hüseyin Atakan ; Baran, Yusuf |
| May-2014 | Bioactive, functional and edible film-forming properties of isolated hazelnut (Corylus avellana L.) meal proteins | Aydemir, Levent Yurdaer; Adan Gökbulut, Aysun ; Baran, Yusuf ; Yemenicioğlu, Ahmet |
| Nov-2017 | Biodiversity, drug discovery, and the future of global health: Introducing the biodiversity to biomedicine consortium, a call to action | Neergheen-Bhujun, Vidushi; Awan, Almas Taj; Baran, Yusuf ; Bunnefeld, Nils; Chan, Kit; Dela Cruz, Thomas Edison; Egamberdieva, Dilfuza; Elsasser, Simon; Johnson, Mari-Vaughn V.; Komai, Shoji; Konevega, Andrey L.; Malone, John H.; Mason, Paul; Nguon, Rothsophal; Piper, Ross; Shrestha, Uttam Babu; Pesic, Milica; Kagansky, Alexander |
| Mar-2023 | Biodiversity: the overlooked source of human health | Linhares, Yuliya; Kaganski, Alexander; Agyare, Christian; Aksan Kurnaz, Işıl; Neergheen, Vidushi; Kolodziejczyk, Bartlomiej; Baran, Yusuf |
| Sep-2008 | Bisphosphonate treatment and radiotherapy in metastatic breast cancer | Ural, Ali Uğur; Avcu, Ferit; Baran, Yusuf |
| 2011 | Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells | Avcı, Çığır Biray; Gündüz, Cumhur; Baran, Yusuf ; Şahin, Fahri; Yılmaz, Sunde; Doğan, Zeynep Özlem; Saydam, Güray |
| Nov-2016 | Cell proliferation and cytotoxicity assays | Adan, Aysun ; Kiraz, Yağmur ; Baran, Yusuf |
| 2010 | Ceramides regulate resveratrol-induced apoptosis in human acute promyelocytic and chronic myeloid leukemia cells | Baran, Yusuf ; Kartal, Melis; Çakır, Zeynep; Saydam, Güray; Şahin, Fahri |
| 2010 | Changes in expression profiles of apoptosis, invasion, metastasis, angiogenesis, transcription factors, cell cycle control and tumour supressor genes in nilotinib treated chronic myeloid leukemia cells | Baran, Yusuf ; Camgöz, Aylin; Can, Geylani |
| 2013 | Changes in gene expression profiles in response to apigenin in imatinib sensitive and resistant chronic myeloid leukemia cells | Baran, Yusuf ; Gökbulut, Aysun ; Cincin, Zeynep; Çakmakoğlu, Bedia; Kozanoğlu, İlknur |
| 2013 | Changes in molecular biology of chronic myeloid leukemia in tyrosine kinase inhibitor era | Cömert, Melda; Baran, Yusuf ; Saydam, Güray |
| May-2013 | Changes in protein profiles of multiple myeloma cells in response to bortezomib | Turan, Taylan; Şanlı Mohamed, Gülşah ; Baran, Yusuf |
| Jun-2010 | Combination of fludarabine and imatinib induces apoptosis synergistically through loss of mitochondrial membrane potential and increases in caspase-3 enzyme activity in human K562 chronic myleloid leukemia cells | Baran, Yusuf ; Öztekin, Coşkun; Başsoy, Esen Yonca |
| Sep-2014 | Comparative development of knowledge-based bioeconomy in the European Union and Turkey | Çelikkanat Ozan, Didem; Baran, Yusuf |
| 2014 | Comparison of ishage-based CD34 (+) cell enumeration protocols on BD facs canto ıı and attune flow cytometers | Kozanoğlu, İlknur; Ünver, Gülşah; Sarıtürk, Çağla; Baran, Yusuf ; Yeral, Mahmut; Boğa, Can; Özdoğu, Hakan |
| 2012 | Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia | Baran, Yusuf ; Saydam, Güray |
| 2014 | Cytotoxic and apoptotic effects of fisetin, hesperetin and vitexinon acute promyelocytic leukemia cells | Adan Gökbulut, Aysun ; Baran, Yusuf |
| 2014 | Cytotoxic and cytostatic effects of ponatinib on imatinib-sensitive and-resistant chronic myeloid leukemia cells | Yandım, Melis Kartal; Baran, Yusuf |
| 2013 | Cytotoxic effects of apigenin on multiple myeloma cells | Baran, Yusuf ; Yılmaz, S. ; Cincin, Zeynep; Kozanoğlu, İlknur; Çakmakoğlu, Bedia; Özdoğu, Hakan |
